RFA-HL-23-010 - Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Application Submission and Due Date Changes for RFA-HL-23-010, "Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)" | NOT-HL-22-015 | NHLBI | Mar 24, 2022 | Apr 15, 2026 | R33 |
For technical issues E-mail OER Webmaster